| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0725 | As1708727 | Novel Foxo1 inhibitor, exerting anti-diabetic and anti-hypertriglyceridemic effects by improving blood glucose and triglyceride metabolism at the gene expression level |
|
| DCC0726 | As1938909 | Novel SHIP2 inhibitor, increasing Akt phosphorylation, glucose consumption, and glucose uptake in L6 myotubes, specifically upregulating the GLUT1 gene |
|
| DCC0727 | As2034178 | Novel GPR40 agonist |
|
| DCC0728 | As3334034 | Novel Receptor-interacting Protein Kinase 2 (RIP2) Inhibitor |
|
| DCC0729 | As-703569 | Selective inhibitor of aurora kinases (AKs) |
|
| DCC0730 | Asah1-in-e2 | Novel angiogenesis inhibitor, directly binding to acid ceramidase 1 (ASAH1) |
|
| DCC0731 | Asc-082 | Novel inhibitor of inositol-requiring enzyme 1 (IRE-1), also inhibiting G protein-coupled receptor kinase 6 (GRK6) |
|
| DCC0732 | Ascochlorin | Natural Suppressor of MMP-2-Mediated Migration and Invasion by Targeting FAK and JAK-STAT Signaling Cascades |
|
| DCC0733 | Ask1 Inhibitor 32 | Novel, Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Modulating Brain Inflammation In Vivo |
|
| DCC0734 | Asm-024 | Novel modulator of acetylcholine receptor function, promoting the in vitro relaxation of β2-adrenoreceptor desensitized tracheas |
|
| DCC0735 | Asm-in-21b | Novel, Potent, Selective, and Direct Acid Sphingomyelinase (ASM) Inhibitor with Antidepressant Activity |
|
| DCC0736 | Asn008 | Novel Permanently-charged Sodium Channel Blocker, Showing Robust Efficacy, a Rapid Onset and Long Duration of Action |
|
| DCC0737 | Asn06917370 | Novel potent GPR17 agonist |
|
| DCC0738 | Asns-in-1 | Novel slow-onset, tight binding, potent asparagine synthetase (ASNS) inhibitor |
|
| DCC0739 | Asoprisnil | Selective progesterone receptor modulator |
|
| DCC0740 | Asp2397 | Novel antifungal agent against Aspergillus isolates |
|
| DCC0741 | Asp5854 | Novel dual A2A/A1 AR antagonist |
|
| DCC0742 | Asp-7962 | Novel tropomyosin-related kinase A (TrkA) inhibitor for the oral treatment of pain due to osteoarthritis of the knee |
|
| DCC0743 | Asp9133 | Novel long-acting muscarinic antagonist (LAMA), showing more selective inhibition of bronchoconstriction against salivation and more rapid onset of action than tiotropium bromide |
|
| DCC0744 | Asp9726 | Novel potent Aspergillus hyphal growth inhibitor |
|
| DCC0745 | asperlicin | Selective antagonist for the cholecystokinin receptor CCKA |
|
| DCC0746 | asperlicin C | Novel cholecystokinin antagonist |
|
| DCC0747 | Asperlicin D | Novel cholecystokinin antagonist |
|
| DCC0748 | Asperphenamate | Natural antineoplastic agent, targeting cathepsin and inducing autophagy effects in breast cancer cells |
|
| DCC0749 | Aspterric Acid | Natural inhibitor of pollen development in Arabidopsis thaliana, also inhibiting dihydroxy-acid dehydratase (DHAD) |
|
| DCC0750 | Aspulvinone E | Natural luciferase inhibitor |
|
| DCC0751 | Aspulvinone H | Natural inhibitor of glutamic oxaloacetate transaminase 1 (GOT1), suppressing glutamine metabolism, making PDAC cells sensitive to oxidative stress and inhibiting cell proliferation, exhibiting potent in vivo antitumor activity in an SW1990-cell-induced x |
|
| DCC0752 | Asr352 | Novel potent anticancer agent, inhibiting the growth of CRC bulk and sensitized FOLFOX-resistant cells |
|
| DCC0753 | Aß/tau Probe 18 | Novel near-infrared (NIR) probe for imaging β-amyloid (Aβ) plaques or Tau tangles |
|
| DCC0754 | Aß-in-10 | Novel anti-Alzheimer’s agent, inhibiting amyloid β aggregation, β-secretase, and tau aggregation |
|
